HEADER HYDROLASE/HYDROLASE INHIBITOR 28-OCT-04 1WAW TITLE SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE TITLE 2 INHIBITOR ARGADIN AGAINST HUMAN CHITINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITOTRIOSIDASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CHITINASE 1; COMPND 5 EC: 3.2.1.14; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ARGADIN; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: CLONOSTACHYS; SOURCE 8 ORGANISM_TAXID: 110564 KEYWDS HUMAN CHITINASE, ARGADIN, CYCLOPENTAPEPTIDE INHIBITORS, CHITINASE KEYWDS 2 INHIBITORS, GLYCOSIDASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON,D.J.ADAMS, AUTHOR 2 K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN REVDAT 11 13-DEC-23 1WAW 1 REMARK REVDAT 10 15-NOV-23 1WAW 1 REMARK LINK ATOM REVDAT 9 24-JUL-19 1WAW 1 REMARK REVDAT 8 10-JUL-19 1WAW 1 REMARK REVDAT 7 22-MAY-19 1WAW 1 REMARK REVDAT 6 24-APR-19 1WAW 1 REMARK SEQRES LINK REVDAT 5 05-AUG-15 1WAW 1 SOURCE REMARK SEQRES HET REVDAT 5 2 1 HETNAM FORMUL LINK HETATM REVDAT 5 3 1 ATOM CONECT REVDAT 4 13-JUL-11 1WAW 1 VERSN REVDAT 3 24-FEB-09 1WAW 1 VERSN REVDAT 2 29-JUN-05 1WAW 1 JRNL REVDAT 1 28-JAN-05 1WAW 0 JRNL AUTH F.V.RAO,D.R.HOUSTON,R.G.BOOT,J.M.F.G.AERTS,M.HODKINSON, JRNL AUTH 2 D.J.ADAMS,K.SHIOMI,S.OMURA,D.M.F.VAN AALTEN JRNL TITL SPECIFICITY AND AFFINITY OF NATURAL PRODUCT JRNL TITL 2 CYCLOPENTAPEPTIDE INHIBITORS AGAINST ASPERGILLUS FUMIGATUS, JRNL TITL 3 HUMAN AND BACTERIAL CHITINASES JRNL REF CHEM.BIOL. V. 12 65 2005 JRNL REFN ISSN 1074-5521 JRNL PMID 15664516 JRNL DOI 10.1016/J.CHEMBIOL.2004.10.013 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 35413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 726 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.020 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3600 REMARK 3 BIN R VALUE (WORKING SET) : 0.5400 REMARK 3 BIN FREE R VALUE : 0.5460 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 1.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 64 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.068 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2925 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 346 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12200 REMARK 3 B22 (A**2) : 0.71800 REMARK 3 B33 (A**2) : -0.84000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.03200 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.82 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.760 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.170 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.070 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 40.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : ARGADIN_CNS.PAR REMARK 3 PARAMETER FILE 5 : COMBINED.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : ARGADIN_CNS.TOP REMARK 3 TOPOLOGY FILE 5 : COMBINED.PAR REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WAW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1290021355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.811 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35505 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1GUV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 31.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.76950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ARGADIN IS CYCLIC PEPTIDE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ARGADIN REMARK 400 CHAIN: B REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 390 REMARK 465 TYR A 391 REMARK 465 LEU A 392 REMARK 465 PRO A 393 REMARK 465 SER A 394 REMARK 465 GLY A 395 REMARK 465 THR A 396 REMARK 465 PRO A 397 REMARK 465 GLU A 398 REMARK 465 LEU A 399 REMARK 465 GLU A 400 REMARK 465 VAL A 401 REMARK 465 PRO A 402 REMARK 465 LYS A 403 REMARK 465 PRO A 404 REMARK 465 GLY A 405 REMARK 465 GLN A 406 REMARK 465 PRO A 407 REMARK 465 SER A 408 REMARK 465 GLU A 409 REMARK 465 PRO A 410 REMARK 465 GLU A 411 REMARK 465 HIS A 412 REMARK 465 GLY A 413 REMARK 465 PRO A 414 REMARK 465 SER A 415 REMARK 465 PRO A 416 REMARK 465 GLY A 417 REMARK 465 GLN A 418 REMARK 465 ASP A 419 REMARK 465 THR A 420 REMARK 465 PHE A 421 REMARK 465 CYS A 422 REMARK 465 GLN A 423 REMARK 465 GLY A 424 REMARK 465 LYS A 425 REMARK 465 ALA A 426 REMARK 465 ASP A 427 REMARK 465 GLY A 428 REMARK 465 LEU A 429 REMARK 465 TYR A 430 REMARK 465 PRO A 431 REMARK 465 ASN A 432 REMARK 465 PRO A 433 REMARK 465 ARG A 434 REMARK 465 GLU A 435 REMARK 465 ARG A 436 REMARK 465 SER A 437 REMARK 465 SER A 438 REMARK 465 PHE A 439 REMARK 465 TYR A 440 REMARK 465 SER A 441 REMARK 465 CYS A 442 REMARK 465 ALA A 443 REMARK 465 ALA A 444 REMARK 465 GLY A 445 REMARK 465 ARG A 446 REMARK 465 LEU A 447 REMARK 465 PHE A 448 REMARK 465 GLN A 449 REMARK 465 GLN A 450 REMARK 465 SER A 451 REMARK 465 CYS A 452 REMARK 465 PRO A 453 REMARK 465 THR A 454 REMARK 465 GLY A 455 REMARK 465 LEU A 456 REMARK 465 VAL A 457 REMARK 465 PHE A 458 REMARK 465 SER A 459 REMARK 465 ASN A 460 REMARK 465 SER A 461 REMARK 465 CYS A 462 REMARK 465 LYS A 463 REMARK 465 CYS A 464 REMARK 465 CYS A 465 REMARK 465 THR A 466 REMARK 465 TRP A 467 REMARK 465 ASN A 468 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 389 CA C O CB CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 153 O HOH A 2150 2.14 REMARK 500 O2 IPA A 1397 O HOH A 2347 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 234 CD GLU A 234 OE2 0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 131 39.45 70.11 REMARK 500 SER A 226 69.01 -150.18 REMARK 500 THR A 266 33.85 -97.74 REMARK 500 ASP A 330 -120.22 57.55 REMARK 500 HSE B1394 -105.78 -158.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 1397 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1398 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF ARGADIN REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GUV RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN CHITOTRIOSIDASE REMARK 900 RELATED ID: 1HKI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH REMARK 900 GLUCOALLOSAMIDIN B REMARK 900 RELATED ID: 1HKJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH REMARK 900 METHYLALLOSAMIDIN REMARK 900 RELATED ID: 1HKK RELATED DB: PDB REMARK 900 HIGH RESOULTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX REMARK 900 WITH ALLOSAMIDIN REMARK 900 RELATED ID: 1HKM RELATED DB: PDB REMARK 900 HIGH RESOULTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX REMARK 900 WITH DEMETHYLALLOSAMIDIN REMARK 900 RELATED ID: 1LG1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH REMARK 900 CHITOBIOSE REMARK 900 RELATED ID: 1LG2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH ETHYLENE REMARK 900 GLYCOL REMARK 900 RELATED ID: 1LQ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE AT 2.2 ANGSTROM REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1WB0 RELATED DB: PDB REMARK 900 SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE REMARK 900 INHIBITOR ARGIFIN AGAINST HUMAN CHITINAES DBREF 1WAW A 22 309 UNP Q13231 CHT1_HUMAN 22 309 DBREF 1WAW A 312 468 UNP Q13231 CHT1_HUMAN 310 466 DBREF 1WAW B 1392 1396 PDB 1WAW 1WAW 1392 1396 SEQRES 1 A 445 ALA LYS LEU VAL CYS TYR PHE THR ASN TRP ALA GLN TYR SEQRES 2 A 445 ARG GLN GLY GLU ALA ARG PHE LEU PRO LYS ASP LEU ASP SEQRES 3 A 445 PRO SER LEU CYS THR HIS LEU ILE TYR ALA PHE ALA GLY SEQRES 4 A 445 MET THR ASN HIS GLN LEU SER THR THR GLU TRP ASN ASP SEQRES 5 A 445 GLU THR LEU TYR GLN GLU PHE ASN GLY LEU LYS LYS MET SEQRES 6 A 445 ASN PRO LYS LEU LYS THR LEU LEU ALA ILE GLY GLY TRP SEQRES 7 A 445 ASN PHE GLY THR GLN LYS PHE THR ASP MET VAL ALA THR SEQRES 8 A 445 ALA ASN ASN ARG GLN THR PHE VAL ASN SER ALA ILE ARG SEQRES 9 A 445 PHE LEU ARG LYS TYR SER PHE ASP GLY LEU ASP LEU ASP SEQRES 10 A 445 TRP GLU TYR PRO GLY SER GLN GLY SER PRO ALA VAL ASP SEQRES 11 A 445 LYS GLU ARG PHE THR THR LEU VAL GLN ASP LEU ALA ASN SEQRES 12 A 445 ALA PHE GLN GLN GLU ALA GLN THR SER GLY LYS GLU ARG SEQRES 13 A 445 LEU LEU LEU SER ALA ALA VAL PRO ALA GLY GLN THR TYR SEQRES 14 A 445 VAL ASP ALA GLY TYR GLU VAL ASP LYS ILE ALA GLN ASN SEQRES 15 A 445 LEU ASP PHE VAL ASN LEU MET ALA TYR ASP PHE HIS GLY SEQRES 16 A 445 SER TRP GLU LYS VAL THR GLY HIS ASN SER PRO LEU TYR SEQRES 17 A 445 LYS ARG GLN GLU GLU SER GLY ALA ALA ALA SER LEU ASN SEQRES 18 A 445 VAL ASP ALA ALA VAL GLN GLN TRP LEU GLN LYS GLY THR SEQRES 19 A 445 PRO ALA SER LYS LEU ILE LEU GLY MET PRO THR TYR GLY SEQRES 20 A 445 ARG SER PHE THR LEU ALA SER SER SER ASP THR ARG VAL SEQRES 21 A 445 GLY ALA PRO ALA THR GLY SER GLY THR PRO GLY PRO PHE SEQRES 22 A 445 THR LYS GLU GLY GLY MET LEU ALA TYR TYR GLU VAL CYS SEQRES 23 A 445 SER TRP LYS GLY ALA THR LYS GLN ARG ILE GLN ASP GLN SEQRES 24 A 445 LYS VAL PRO TYR ILE PHE ARG ASP ASN GLN TRP VAL GLY SEQRES 25 A 445 PHE ASP ASP VAL GLU SER PHE LYS THR LYS VAL SER TYR SEQRES 26 A 445 LEU LYS GLN LYS GLY LEU GLY GLY ALA MET VAL TRP ALA SEQRES 27 A 445 LEU ASP LEU ASP ASP PHE ALA GLY PHE SER CYS ASN GLN SEQRES 28 A 445 GLY ARG TYR PRO LEU ILE GLN THR LEU ARG GLN GLU LEU SEQRES 29 A 445 SER LEU PRO TYR LEU PRO SER GLY THR PRO GLU LEU GLU SEQRES 30 A 445 VAL PRO LYS PRO GLY GLN PRO SER GLU PRO GLU HIS GLY SEQRES 31 A 445 PRO SER PRO GLY GLN ASP THR PHE CYS GLN GLY LYS ALA SEQRES 32 A 445 ASP GLY LEU TYR PRO ASN PRO ARG GLU ARG SER SER PHE SEQRES 33 A 445 TYR SER CYS ALA ALA GLY ARG LEU PHE GLN GLN SER CYS SEQRES 34 A 445 PRO THR GLY LEU VAL PHE SER ASN SER CYS LYS CYS CYS SEQRES 35 A 445 THR TRP ASN SEQRES 1 B 5 0AR DPR HSE HIS UN1 MODRES 1WAW 0AR B 1392 ARG MODRES 1WAW HSE B 1394 SER L-HOMOSERINE HET 0AR B1392 14 HET DPR B1393 7 HET HSE B1394 7 HET UN1 B1396 10 HET GOL A1389 6 HET GOL A1390 6 HET GOL A1391 6 HET IPA A1397 4 HET SO4 A1398 5 HETNAM 0AR N-[N-[(4S)-4-AZANYL-5-HYDROXY-5-OXO- HETNAM 2 0AR PENTYL]CARBAMIMIDOYL]ETHANAMIDE HETNAM DPR D-PROLINE HETNAM HSE L-HOMOSERINE HETNAM UN1 2-AMINOHEXANEDIOIC ACID HETNAM GOL GLYCEROL HETNAM IPA ISOPROPYL ALCOHOL HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN IPA 2-PROPANOL FORMUL 2 0AR C8 H16 N4 O3 FORMUL 2 DPR C5 H9 N O2 FORMUL 2 HSE C4 H9 N O3 FORMUL 2 UN1 C6 H11 N O4 FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 IPA C3 H8 O FORMUL 7 SO4 O4 S 2- FORMUL 8 HOH *346(H2 O) HELIX 1 1 TRP A 31 ARG A 35 5 5 HELIX 2 2 GLN A 36 ARG A 40 5 5 HELIX 3 3 LEU A 42 LEU A 46 5 5 HELIX 4 4 ASN A 72 GLY A 82 1 11 HELIX 5 5 LEU A 83 MET A 86 5 4 HELIX 6 6 THR A 103 ALA A 111 1 9 HELIX 7 7 THR A 112 SER A 131 1 20 HELIX 8 8 VAL A 150 GLY A 174 1 25 HELIX 9 9 GLY A 187 TYR A 195 1 9 HELIX 10 10 GLU A 196 LEU A 204 1 9 HELIX 11 11 SER A 235 LEU A 241 5 7 HELIX 12 12 ASN A 242 LYS A 253 1 12 HELIX 13 13 PRO A 256 SER A 258 5 3 HELIX 14 14 TYR A 303 CYS A 307 1 5 HELIX 15 15 ASP A 338 LYS A 352 1 15 HELIX 16 16 ALA A 361 ASP A 365 5 5 HELIX 17 17 TYR A 377 SER A 388 1 12 SHEET 1 AA11 LYS A 23 THR A 29 0 SHEET 2 AA11 GLY A 356 TRP A 360 1 O ALA A 357 N VAL A 25 SHEET 3 AA11 LEU A 260 PRO A 265 1 O LEU A 262 N MET A 358 SHEET 4 AA11 PHE A 206 MET A 210 1 O VAL A 207 N ILE A 261 SHEET 5 AA11 LEU A 179 PRO A 185 1 O ALA A 182 N ASN A 208 SHEET 6 AA11 GLY A 134 ASP A 138 1 O LEU A 135 N SER A 181 SHEET 7 AA11 LYS A 91 GLY A 97 1 O LEU A 94 N ASP A 136 SHEET 8 AA11 HIS A 53 THR A 62 1 O LEU A 54 N LEU A 93 SHEET 9 AA11 LYS A 23 THR A 29 1 O CYS A 26 N ILE A 55 SHEET 10 AA11 GLY A 356 TRP A 360 1 O ALA A 357 N VAL A 25 SHEET 11 AA11 LYS A 23 THR A 29 1 O LYS A 23 N ALA A 357 SHEET 1 AB 8 ALA A 285 SER A 288 0 SHEET 2 AB 8 TYR A 267 LEU A 273 -1 O THR A 272 N THR A 286 SHEET 3 AB 8 MET A 300 ALA A 302 -1 O LEU A 301 N GLY A 268 SHEET 4 AB 8 TYR A 267 LEU A 273 -1 O GLY A 268 N LEU A 301 SHEET 5 AB 8 THR A 315 ILE A 319 0 SHEET 6 AB 8 VAL A 324 ARG A 329 -1 O VAL A 324 N ILE A 319 SHEET 7 AB 8 GLN A 332 GLY A 335 -1 O GLN A 332 N ARG A 329 SHEET 8 AB 8 TYR A 267 LEU A 273 -1 O ARG A 269 N GLY A 335 SSBOND 1 CYS A 26 CYS A 51 1555 1555 2.03 SSBOND 2 CYS A 307 CYS A 372 1555 1555 2.03 LINK C 0AR B1392 N DPR B1393 1555 1555 1.33 LINK N 0AR B1392 C UN1 B1396 1555 1555 1.33 LINK C DPR B1393 N HSE B1394 1555 1555 1.33 LINK C4 HSE B1394 N HIS B1395 1555 1555 1.47 LINK C HSE B1394 N HIS B1395 1555 1555 1.33 LINK C HIS B1395 N UN1 B1396 1555 1555 1.33 CISPEP 1 ALA A 57 PHE A 58 0 -1.95 CISPEP 2 GLU A 140 TYR A 141 0 0.70 CISPEP 3 TRP A 360 ALA A 361 0 -1.05 SITE 1 AC1 9 TYR A 141 PRO A 185 ALA A 186 GLY A 187 SITE 2 AC1 9 MET A 210 TYR A 212 ASP A 213 HOH A2339 SITE 3 AC1 9 HOH A2340 SITE 1 AC2 6 ASP A 47 LEU A 50 LYS A 152 GLN A 381 SITE 2 AC2 6 HOH A2189 HOH A2341 SITE 1 AC3 8 SER A 217 TRP A 218 ARG A 269 GLY A 298 SITE 2 AC3 8 GLY A 299 HOH A2273 HOH A2342 DPR B1393 SITE 1 AC4 6 ARG A 177 GLN A 202 ASN A 203 ASP A 205 SITE 2 AC4 6 HOH A2202 HOH A2347 SITE 1 AC5 2 HOH A2349 HOH A2350 SITE 1 AC6 21 TYR A 27 TRP A 99 ASP A 138 GLU A 140 SITE 2 AC6 21 ALA A 183 MET A 210 TYR A 212 ASP A 213 SITE 3 AC6 21 TRP A 218 TYR A 267 ARG A 269 GLU A 297 SITE 4 AC6 21 MET A 300 TRP A 360 GOL A1391 HOH A2187 SITE 5 AC6 21 HOH A2205 HOH B2343 HOH B2344 HOH B2345 SITE 6 AC6 21 HOH B2346 CRYST1 45.293 47.539 84.630 90.00 102.20 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022078 0.000000 0.004774 0.00000 SCALE2 0.000000 0.021035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012089 0.00000